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Abstract
Background: Bacterial meningitis is often associated with cerebral compromise which may be
responsible for neurological sequelae in nearly half of the survivors. Little is known about the
mechanisms of CNS involvement in bacterial meningitis. Several studies have provided substantial
evidence for the key role of nitric oxide (NO) and reactive oxygen species in the complex
pathophysiology of bacterial meningitis.
Methods: In the present study, serum and CSF levels of NO, lipid peroxide (LPO) (mediators for
oxidative stress and lipid peroxidation); total thiol, superoxide dismutase (SOD) (antioxidant
mediators) and S-100B protein (mediator of astrocytes activation and injury), were investigated in
children with bacterial meningitis (n = 40). Albumin ratio (CSF/serum) is a marker of blood-CSF
barriers integrity, while mediator index (mediator ratio/albumin ratio) is indicative of intrathecal
synthesis.
Results: Compared to normal children (n = 20), patients had lower serum albumin but higher NO,
LPO, total thiol, SOD and S-100B. The ratios and indices of NO and LPO indicate blood-CSF
barriers dysfunction, while the ratio of S-100B indicates intrathecal synthesis. Changes were
marked among patients with positive culture and those with neurological complications. Positive
correlation was found between NO index with CSF WBCs (r = 0.319, p < 0.05); CSF-LPO with
CSF-protein (r = 0.423, p < 0.01); total thiol with LPO indices (r = 0.725, p < 0.0001); S-100B and
Pediatric Glasow Coma Scores (0.608, p < 0.0001); CSF-LPO with CSF-S-100B (r = 0.482, p <
0.002); serum-total thiol with serum S-100B (r = 0.423, p < 0.01).
Conclusion: This study suggests that loss of integrity of brain-CSF barriers, oxidative stress and
S-100B may contribute to the severity and neurological complications of bacterial meningitis.
Background
Bacterial meningitis is the most severe and frequent infec-
tion of the central nervous system (CNS). It remains an
important public health problem worldwide[1]. Even
with antimicrobial therapy and the availability of
advanced intensive care, the mortality rate of bacterial
meningitis is ~25% in industrialized countries [2] and
much higher in the developing world[1]. Several studies
confirmed that brain damage is responsible for neurolog-
ical sequelae in 50% of survivors after bacterial meningi-
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tis. Many of the complications may persist to
adulthood[3,4]. Bedford et al. [3] evaluated 1584 children
aged 5 years who had survived bacterial meningitis during
the first year of life and found a 10-fold increase in the risk
of having moderate to severe disabilities with 7.5% had
learning difficulties, 8.1% had neuro-motor disabilities,
7.3% had seizure disorders, 25.8% had hearing problems
and 11.9% had behavioral problems. Grimwood et al. [4]
evaluated 109 children at adolescence (12 years of age)
who had survived bacterial meningitis at 7 years of age
and found that many of the deficits identified at the 7-year
follow-up had persisted, with 9% of the patients had
major neurological, auditory, or intellectual impairments
and 30% had less severe disabilities, compared with 11%
of the controls.
The mechanisms of CNS damage during meningitis have
not been conclusively identified. During bacterial infec-
tions, neutrophils and macrophages gather at the site of
infection to combat the microorganisms. Blood-derived
and brain-resident immune cells employ reactive oxygen
species (ROS) as part of their host defense mechanisms
against invading bacteria. In this process, these cells con-
sume molecular oxygen, which is converted into toxic
superoxide anion (O2.), hydrogen peroxide and hydroxyl
radical [5-7] Under normal circumstances, ROS are elimi-
nated by cellular enzymatic [as superoxide dismutase
(SOD) and catalase] and non-enzymatic [as glutathione
and uric acid] antioxidants defenses[8]. Thus, if ROS are
not effectively removed due to exhaustion of antioxidant
capacity, an imbalance between oxidant and antioxidant
activities will result in oxidative stress which includes per-
oxidation of membrane lipids, as well as damage on pro-
teins and DNA. This may contributes to the development
of several pathologic processes in bacterial meningi-
tis[8,9]. On the other hand, astrocytes are the most abun-
dant cell type in the brain and involved in a variety of
important activities for the nervous system, including a
protective role against damage induced by ROS[10]. S-
100B is a calcium binding protein physiologically pro-
duced mainly by astrocytes in CNS and has been impli-
cated in the development and maintenance of the nervous
system. Although the mechanism of S-100B secretion is
unknown, it appears to be affected by oxidative stress. At
nanomolar concentrations (normal levels), S-100B is able
to protect neurons against glutamate toxicity[11]. On the
other hand, high levels of S-100B (micromolar) as a result
of glial damage or astrocytic reactions to neural injury
(reactive astrogliosis) will further increase neuronal dam-
age[12]. High levels of S-100B have been considered as a
biomarker that could indicate damage or dysfunction of
CNS[13].
The relationship between S-100B and oxidative stress/
antioxidant mechanisms in patients with bacterial menin-
gitis is barely determined. Given the fact that improve-
ments in antibiotic therapy are unlikely to substantially
change the outcome of meningitis, it is imperative to con-
tinue efforts to obtain a better understanding of the
pathogenesis of brain damage resulting from meningitis.
Aim of the work
The present study may contribute to further understand-
ing of factors involved in brain compromise associated
with bacterial meningitis. Oxidant and antioxidant activi-
ties were assessed by measuring serum and CSF levels of
NO, lipid peroxide (LPO) (markers of oxidative stress and
lipid peroxidation); total Thiol and superoxide dismutase
(SOD) (markers of antioxidant activity). S-100B protein is
a marker of astrocytic reaction or glial damage[11]. We
investigated whether enhancement of these markers indi-
cate blood-CSF barriers' dysfunction or due to intrathecal
synthesis as a result of the inflammatory process. We also
investigated the relationship of these markers to the pres-
ence of the organisms. The correlations between S-100B
and oxidative stress/antioxidant markers for causal rela-
tionship for the severity and neurological complications
of bacterial meningitis were discussed.
Methods
All consecutive children (n = 40; male: 29, female = 11),
aged <15 years (mean: 71.8 ± 8.23 months), blood pres-
sure (99 ± 19 mmHg), admitted to the Pediatric Depart-
ment, Hospital of Infectious Diseases (Fever Hospital),
Assiut, Egypt, carried the diagnosis of bacterial meningitis,
were included in this study. Septic meningitis was diag-
nosed by the presence of the following: CSF polymorpho-
nuclear cell count > 5 mm3, CSF: blood glucose ratio
<60% or CSF glucose < 40 mg/dl and protein > 40 mg/dl
in absence of CSF hemorrhage and positive CSF cul-
ture[1]. Inclusion was also dependent on the decision to
perform a lumbar tap on admission. Twenty healthy chil-
dren matched for age (mean: 51.5 ± 4.09 months) and sex
(male: 12, female = 8) were included for comparison. This
study was conducted according to the principles estab-
lished in Helsinki and approved by Assiut University Hos-
pital ethics committee. Informed consent was obtained
from the parents/guardians. Excluded from the study were
children with: 1) Sepsis, severe sepsis and septicemic
shock[14]. The diagnosis of sepsis was based on the pres-
ence of positive blood culture for bacteria in additions to
clinical manifestations of sepsis, 2) viral meningitis or
encephalitis: Viral CNS infection is diagnosed in the pres-
ence of pleocytosis (up to 1000 leukocytes/mm3) with
predominance of mononuclear cells, normal CSF glucose
and chloride concentrations and normal or increased pro-
tein. We did not do CSF culture, serology or PCR for neu-
rotropic viruses, 3) fetal and neonatal malformations;
chromosomal abnormalities or developmental delay, 4)
perinatal asphyxia, 5) immunodeficiency, 6) endocrineBMC Neurology 2009, 9:51 http://www.biomedcentral.com/1471-2377/9/51
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diseases as diabetes mellitus and obesity, 7) purpura, 8)
impairment of hearing prior to diagnosis of sepsis, 9) neu-
romuscular diseases, and 10) recent neurosurgery or ven-
triculoperitoneal shunt.
Data collection
Clinical data were collected as follow: 1) demographics
(age, gender, weight and hospital admission date), coex-
isting medical conditions, antibiotic pretreatment, vacci-
nation status, temperature and duration of fever at the
time of presentation and occurrence and timing of sei-
zures, 2) physical examination findings, 3) routine tests
for biochemistry and hematology were done on the date
of lumbar tap including complete blood count, kidney
and liver function tests, 4) chest x-ray, urine and stool
analyses were done as indicated per patient, 5) CSF anal-
ysis included white and differential cell count, protein
and glucose concentrations, gram-stained CSF smear
examination and culture for bacteria, 6) the severity of
brain involvement was assessed using the Pediatric Glas-
gow Coma Scale or scoring system (PGCS)[15]. This is an
equivalent of the Glasgow Coma Scale (GCS) used to
assess the mental state of adult patients. As many of the
assessments for adults would not be appropriate for
infants and children below 36 months, the scale was mod-
ified slightly. As with the GCS, the PGCS comprises three
tests: eye, verbal and motor responses. The three values
separately as well as their sum are considered. Accord-
ingly, the degrees of severity are mild (PGCS: 13-15),
moderate (PGCS: 9-12) and severe (PGCS: ≤ 8). The low-
est possible PGCS (the sum) is 3 (deep coma) whilst the
highest is 15 (fully awake and aware), and 7) electroen-
cephalography (EEG) and neuroimaging (CT or MRI
brain) were done for all patients.
Upon hospital discharge (survivors or non-survivors),
summary data including total hospital stay and complica-
tions were collected for all patients.
Sample Collection
Serum and CSF samples were collected from patients
upon admission. Only blood samples were obtained from
the control children as our ethical committee did not per-
mit CSF intake from normal children. CSF was collected
under strict non-infected conditions. Standard hemato-
logical and biochemical analysis of peripheral blood were
also documented. All samples were tested for white blood
cell count with differential and bacterial cultures. Levels of
CSF glucose, protein were determined by routine labora-
tory procedures. Methods for CSF processing and bacterial
culture used in this study have been described previ-
ously[16]. Briefly, CSF was inspected for appearance and
processed for differential leukocyte cell count and glu-
cose/protein levels. Microbiologic analysis included
gram-stain and bacterial culture on blood, MacConkey
and chocolate agar plates. Samples collected after hours
were inoculated into trans-isolate medium and cultured
on plates on the next day. For exclusion of mycobacterium
tuberculosis, CSF samples were inoculated into Lowen-
stein-Jensen medium (Becton Dickinson, Franklin Lakes,
NJ, USA). The decision to perform mycobacterium tuber-
culosis cultures was made at the discretion of the admit-
ting physician. The remaining serum and cerebrospinal
fluid samples were spun down, and the supernatant was
frozen at -70°C until assayed.
Mediator assays
a) Determination of the serum and CSF concentrations of specific 
mediators
Nitric oxide (NO) was determined by a classic griess reac-
tion with sulfanilic acid and alpha naphthylamine in
diluted sulfuric acid medium as described by Ding et
al[17]. LPO was measured by method as described by
Grau et al[18]. Superoxide dismutase (SOD) activity and
total thiol (total -SH group) content were determined
spectrophotometrically according to the method
described by Bannister et al[19]. The S-100B protein con-
centration was measured by a commercially available
immunoluminometric assay (ELISA kits, BioVendor Lab-
oratorni Medicina, A.S.) as supplied by the manufacturer's
standards. The sensitivity of the kit was 0.1 ng/ml. All
serum samples were diluted in diluents buffer provided
with the kits while CSF assay was performed on non-
diluted samples according to the manufacturer's instruc-
tions. Samples and standards were run in duplicate.
b) Determination of the CSF-to-serum ratios and indices of specific 
mediators
Albumin is an exclusively blood-derived CSF protein. It is
transferred to the CSF via passive diffusion through the
intact blood-CSF barriers. The CSF-to-serum albumin
concentration was found to be 1:205. Increased albumin
concentrations in CSF must always be due to blood CSF
barrier dysfunction. In this study, albumin ratio (albumin
CSF concentration × 103/albumin serum concentration)
was calculated as an indicator of blood-CSF barrier dys-
function in patients with meningitis[20]. Also by compar-
ing a specific biomarker or mediator ratio (mediator CSF
concentration × 103/mediator serum concentration) with
the albumin ratio (normalizing to albumin), it is possible
to infer whether the mediators of similar molecular
weight to albumin are passively transferred across the dis-
rupted blood-CSF barriers or intrathecally synthesized.
The latter is indicated by calculation of the blood-derived
mediator indices as follow: mediator index is equal to the
mediator ratio (CSF/serum) divided by albumin ratio
(CSF/serum). The higher the mediator ratio than albumin
ratio indicates local intrathecal substance production.
Estimation of marker indices seems to have a significance
for blood-deriver proteins or substances but it is not appli-BMC Neurology 2009, 9:51 http://www.biomedcentral.com/1471-2377/9/51
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cable for brain-derived proteins or substances as S-100B
which has an intrathecal fraction of ~99% (CSF/serum
ratio: 18:1; which mean that S-100B is 18 times higher in
CSF than the serum)[21]. The serum and CSF albumin
were measured by ELISA kit obtained from Egyptian Com-
pany for Biotechnology; Cairo, Egypt, detection limit of
the assay was 1.0 g/dl.
Statistical Analysis
The analysis was done using SPSS version 11.5. Data were
expressed as mean ± 2SD or as a percentage when appro-
priate. One-way ANOVA or Mann-Whitney U tests were
used for comparison between different groups. The Pear-
son's and Spearman correlation coefficient tests were used
to evaluate associations between measured parameters
(continuous and non-continuous variables). For all tests,
p < 0.05 was considered significant.
Results
This is a cross-sectional study. CSF biochemistries of the
samples examined confirmed the diagnosis of bacterial
meningitis (glucose: 49 ± 26 mg/ml; protein: 94 ± 83 mg/
dl; cells count: 58,350 ± 18431 cells/cm3, neutrophils: 92
± 13% and lymphocytes: 8 ± 13%) as compared to our
normal lab reference values (glucose: 75 ± 11 mg/ml; pro-
tein: 22 ± 7 mg/dl; cells count: ± 4 cells/cm3). CSF-culture
was positive in 37.5% (n = 15) of patients. Organisms
identified were streptococcus pneumonia (n = 6, 40%),
staphylococcus aureus (n = 4, 26.7%), haemophilus influ-
enza (n = 3, 20%) and neisseria meningitides (n = 2,
13.3%).
The frequent presenting clinical manifestations include:
fever (range: 38-40°C, mean: 39°C), vomiting (n = 27,
67.5%), headache (n = 26, 65%), seizures (n = 22, 55%),
nuchal rigidity (n = 17, 42.5%), drowsiness (n = 15,
37.5%), diarrhea (n = 11, 27.5%), cough (n = 10, 25%)
and bleeding tendency (n = 1, 2.5%). According to PGCS,
moderate (n = 12, 30%) to severe (n = 4, 10%) scores were
identified in 40% of children. Fundus examination was
normal. Neurological evaluation at the time of hospital
discharge (range: 6-13 days, mean: 8.13 ± 1.51) revealed
persistence of specific neurological manifestations in
12.5% (n = 5) of patients in the form of squint (6th cranial
nerve palsy) (n = 2; 5%) and rigidity of the 4 limbs (n = 3;
7.5%). Headache and drowsiness without other manifes-
tations were observed in 30% (n = 12) which may be non-
specific manifestations due to medications. Three patients
with rigidity had streptococcus pneumonia and the 2
patients with 6th cranial nerve palsy had haemophilus
influenzae and Neisseria meningitidis (one patient each).
Mortality rate was 5% (n = 2). Organisms identified were
streptococcus pneumonia (n = 6, 40%), staphylococcus
aureus (n = 4, 26.7%), haemophilus influenza (n = 3,
20%) and neisseria meningitides (n = 2, 13.3%). The high
rate of culture negative disease (n = 25, 62.5%) was caused
by multiple factors including the use of antibiotics before
admission, a common problem in Egypt and many other
developing countries [16] or rapidly processing CSF cul-
ture. However, the relatively higher ratio of positive cul-
ture (37.5%) despite that 27.5% of patients received
antibiotics was attributed to early admission after onset
and CSF sampling in the majority of patients.
Table 1 showed the serum and CSF concentrations of
albumin, NO, LPO, total thiol, SOD and S-100B protein.
Compared to healthy children, serum albumin was lower,
while serum S-100B (p < 0.05), NO, LPO, total thiol, SOD
were higher in patients with meningitis. Table 2 compared
the measured parameters in patients with positive and
negative bacterial CSF culture. It was found that serum S-
100B, serum NO, total CSF thiol and total thiol index
were higher in patients with positive CSF culture com-
pared to patients with negative cultures. In Table 3, S-
100B ratio and serum ratio and indices of NO and SOD
were higher in patients with neurological complications
compared to patients without neurological complica-
tions.
In patients with meningitis, Positive correlation was
found between NO index with CSF white blood cells (r =
0.319, p < 0.05); CSF-LPO with CSF-protein (r = 0.423, p
< 0.01); NO and LPO indices (r = 0.318, p < 0.05); total
thiol with LPO indices (r = 0.725, p < 0.0001); S-100B and
PGCS (0.608, p < 0.0001); CSF-LPO with CSF-S-100B (r =
0.482, p < 0.002); serum-total thiol with serum S-100B (r
= 0.423, p < 0.01). In healthy controls, a positive correla-
tion was found between serum S-100B with serum LPO (r
= 0.498, p < 0.05).
Discussion
The results of this study may suggest the following: 1)
Dysfunction of blood-CSF barriers occurs with bacterial
meningitis, 2) Oxidative stress has an important role in
the pathogenesis of bacterial meningitis, 2) Brain damage
does occur in bacterial meningitis as evidence by
increased intrathecal synthesis of S-100B, NO and LPO
biomarkers, 3) the finding of association between the lev-
els of mediators of oxidative stress, antioxidants and S-
100B may suggest their role in disease severity and the
occurrence of neurological complications.
In the present study, the increased albumin ratio (CSF/
serum) is an indicator of morphological and/or biophysi-
cal dysfunction of the blood CSF barriers caused by
inflammation. Albumin is the main fraction (80%) of CSF
proteins. Increased albumin concentrations in CSF must
always be due to blood CSF barriers dysfunction (100%
blood-derived protein). Furthermore, it has been sug-
gested that the mediators' CSF-to-serum ratio and indicesBMC Neurology 2009, 9:51 http://www.biomedcentral.com/1471-2377/9/51
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(mediator CSF-to-serum ratio/albumin CSF-to-serum
ratio) are better for diagnostic purposes rather than rely-
ing on CSF concentrations only and to infer whether the
blood-derived mediators of similar molecular weight to
albumin are passively transferred across the disrupted
blood-CSF barriers or intrathecally synthesized. This has
been attributed to the fact the difference in the CSF levels
of these mediators throughout the day caused by CSF
turnover and the to-and-fro motions of the CSF by cardiac
cycles or the circadian rhythms. According to the laws of
diffusion, it is important to know that all blood proteins
traverse capillary walls of blood-CSF barriers by passive
diffusion (molecular flux) into brain, extracellular fluid
and CSF according to their molecular weight, e.g. smaller
molecules like IgG (150 kDa) (serum/CSF ratio: 500:1),
albumin (67 kDa) (serum/CSF ratio: 205:1) are fast in
exchange than large molecules e.g. IgM (900 kDa) which
are slower in exchange and subsequently form a steeper
blood-to-CSF concentration gradient (IgM: serum/CSF
ratio: 3400:1)[20,21].
In this study, serum and CSF levels of NO were elevated in
children with meningitis. NO CSF/serum ratio and index
are suggestive of local production in the CNS as well as
passage through the disturbed blood brain barrier. Some
authors suggested that the increased level of CSF-NO in
patients with bacterial meningitis is due to blood-CSF bar-
riers dysfunction or disturbed permeability as a result of
the inflammatory process[22,23]. Bacteria are thought to
enter the CNS either by local tissue damage or by transcy-
Table 1: Oxidative stress, antioxidant biomarkers and S-100B protein levels in the serum and CSF of the studied group
Mediators Patients
(n = 40)
Controls
(n = 20)
CSF Serum CSF/serum
ratio (10-3)
Index Serum
Albumin* (g/dl)
mean ± 2SD 1.27 ± 0.08 2.53 ± 0.41 513.78 ± 80.87 - 3.94 ± 1.03
Range 1.10-1.51 2.09-3.21 395.64-604.03 2.27-5.40
Significance p < 0.0001
NO (nmol/ml)
mean ± 2SD 16.21 ± 1.73 23.02 ± 7.90 927.34 ± 190.69 1.86 ± 0.54 14.64 ± 2.41
Range 13.49-21.55 15.08-45.95 898.03-1453.96 1.25-2.94 10.73-20.62
Significance p < 0.01
LPO (μmol/l)
mean ± 2SD 14.49 ± 1.13 17.89 ± 2.56 825.48 ± 134.26 1.66 ± 0.42 6.78 ± 1.00
Range 12.54-15.88 12.38-22.85 642.89-1205.17 1.08-2.50 5.40-8.10
Significance p < 0.0001
Total Thiol (nmol/ml)
mean ± 2SD 0.56 ± 0.20 6.10 ± 2.55 24.11 ± 9.39 0.05 ± 0.02 1.13 ± 0.34
Range 0.28-1.25 1.63-10.66 9.06-41.39 0.02-0.1 0.79-1.80
Significance p < 0.0001
SOD (U/g protein)
mean ± 2SD 2.87 ± 1.06 3.30 ± 1.20 122.75 ± 52.70 0.24 ± 0.11 1.08 ± 0.20
Range 49.34-2077.48 1.22-6.97 40.43-298.06 0.08-0.62 0.78-1.34
Significance p < 0.0001
S100 B (ng/ml)
mean ± 2SD 0.61 ± 0.05 0.22 ± 0.13 2772.73 ± 188.48 - 0.13 ± 0.02
Range 0.55-0.70 0.13-0.57 1228.07-4230.77 0.11-0.16
Significance p < 0.05
One-way ANOVA or *Mann-Whitney U tests were used for comparison between different groups
CSF: cerebrospinal fluid; NO: nitric oxide; LPO: lipid peroxide; SOD: superoxide dismutase
Albumin ratio = [albumin CSF level] × 103
[albumin serum level]
Mediator ratio = [mediator CSF level] × 103
[mediator serum level]
Mediator index = [mediator CSF level]/[mediator serum level] [albumin CSF level]/[albumin serum level]BMC Neurology 2009, 9:51 http://www.biomedcentral.com/1471-2377/9/51
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Table 2: Comparison between the serum and CSF concentrations of oxidative stress, antioxidant biomarkers and S-100B protein 
among patients with positive and negative CSF culture for bacteria
Mediators Patients with positive bacterial culture (n = 15) Patients with negative bacterial culture (n = 25)
CSF serum CSF/serum
ratio (10-3)
Index CSF serum CSF/serum
ratio (10-3)
Index
Albumin* (g/dl) 1.27 ± 0.06 2.50 ± 0.50 526.01 ± 113.21 - 1.29 ± 0.10 2.55 ± 0.43 523.45 ± 109.36 -
Significance p > 0.05 p >0.05 p > 0.05
NO (nmol/ml) 15.75 ± 1.06 28.55 ± 12.30 694.15 ± 175.22 1.37 ± 0.42 17.24 ± 3.27 23.36 ± 7.77 731.35 ± 194.58 1.44 ± 0.44
Significance p > 0.05 p < 0.01 p > 0.05 p > 0.05
LPO (umol/l) 17.53 ± 3.2 24.31 ± 4.98 741.02 ± 152.27 1.47 ± 0.41 17.79 ± 3.51 24.54 ± 6.41 767.36 ± 217.24 1.53 ± 0.53
Significance p > 0.05 p > 0.05 p > 0.05 p > 0.05
Total Thiol 
(nmol/ml)
0.63 ± 0.27 6.09 ± 3.07 26.78 ± 11.35 0.05 ± 0.03 0.52 ± 0.13 6.11 ± 2.25 22.51 ± 7.81 0.04 ± 0.02
Significance p < 0.01 p > 0.05 p > 0.05 p < 0.05
SOD (U/g protein) 3.21 ± 1.22 3.89 ± 1.36 133.08 ± 49.53 0.26 ± 0.12 2.66 ± 0.91 2.94 ± 0.94 116.55 ± 54.54 0.23 ± 0.11
Significance p > 0.05 p > 0.05 p > 0.05 p > 0.05
S100 B (ng/ml) 0.61 ± 0.38 0.70 ± 0.21 945.97 ± 687.62 - 0.66 ± 0.11 0.58 ± 0.42 844.21 ± 555.64 -
Significance p > 0.05 p < 0.05 p > 0.05
One-way ANOVA or *Mann-Whitney U tests were used for comparison between different groups CSF: cerebrospinal fluid; NO: nitric oxide; LPO: 
lipid peroxide; SOD: superoxide dismutase
Table 3: Comparison between the serum and CSF concentrations of oxidative stress, antioxidant biomarkers and S-100B protein 
among patients with and without neurological complications
Mediators Patients with neurological complications (n = 7) Patients without neurological complications (n = 35)
CSF serum CSF/serum
ratio (10-3)
Index CSF serum CSF/serum
ratio (10-3)
Index
Albumin* (g/dl) 1.35 ± 0.05 2.55 ± 0.43 529.41 ± 94.55 - 1.27 ± 0.43 2.45 ± 0.45 518.37 ± 112.6 -
Significance p > 0.05 p > 0.05 p > 0.05
NO (nmol/ml) 18.41 ± 1.42 29.70 ± 12.03 620.69 ± 176.07 1.17 ± 0.47 10.91 ± 2.87 22.38 ± 9.68 487.49 ± 190.37 0.94 ± 0.22
Significance p < 0.05 p < 0.05 p < 0.05 p < 0.05
LPO (umol/l) 13.64 ± 2.68 20.24 ± 6.11 673.90 ± 150.47 1.26 ± 0.40 11.70 ± 3.49 28.14 ± 5.84 415.77 ± 200.30 0.80 ± 0.05
Significance p < 0.05 p < 0.05 p < 0.01 p < 0.05
Total Thiol 
(nmol/ml)
0.69 ± 0.32 6.04 ± 3.07 31.87 ± 12.31 0.07 ± 0.03 0.53 ± 0.16 6.11 ± 2.51 22.74 ± 8.27 0.04 ± 0.02
Significance p > 0.05 p > 0.05 p > 0.05 p > 0.05
SOD (U/g protein) 3.47 ± 1.30 4.35 ± 1.96 157.47 ± 56.66 0.34 ± 0.11 2.76 ± 0.99 3.11 ± 0.93 116.62 ± 50.37 0.23 ± 0.11
Significance p > 0.05 p < 0.01 p > 0.05 p > 0.05
S100 B (ng/ml) 0.67 ± 0.42 0. 24 ± 0.07 2791.67 ± 754.77 - 0.25 ± 0.40 0.15 ± 0.16 1666.67 ± 573.2 -
Significance p < 0.01 P < 0.01 p < 0.001
One-way ANOVA or *Mann-Whitney U tests were used for comparison between different groups
CSF: cerebrospinal fluid; NO: nitric oxide; LPO: lipid peroxide; SOD: superoxide dismutaseBMC Neurology 2009, 9:51 http://www.biomedcentral.com/1471-2377/9/51
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tosis through microvascular endothelial cells[24,25]. And,
as host defense mechanisms are limited in the CSF, bacte-
ria can multiply and reach titers of up to hundred(s) col-
ony-forming units per milliliter. In response to bacterial
cell wall components released by autolysis, the rapid
increase of proinflammatory cytokines [tumor necrosis
factor-a (TNF-a) and interleukins 1b and 6] and chemok-
ines [interleukin-8, macrophage inflammatory protein
(MIP)-1 and MIP-2] is followed by the appearance of
granulocytes and this resulted in enhanced blood-brain
barrier permeability[26]. It has been suggested that NO-
related compounds, most probably ONOO- released
from infiltrating inflammatory and endothelial cells, may
cause loss of integrity of the blood-CSF barriers. Other
studies reported no destruction in blood-CSF barriers with
meningitis and claimed increased CSF-NO to local pro-
duction during the course of the inflammatory process
which is mediated by cytokines[22]. Marra et al[27].
found infection of the brain without detectable bactere-
mia in a pneumococcal respiratory tract infection model
indicating that pneumococci are able to disseminate by a
non-hematogenous route. In contrast, some studies did
not find changes in the CSF-NO with bacterial meningi-
tis[28]. A possible explanation for this discrepancy would
be a difference in the study subjects and severity of the dis-
ease.
A positive correlation was found between NO-index and
CSF-WBCs. Another interesting result in this study is that
the serum-NO level was higher in patients with gram pos-
itive CSF culture compared to negative culture indicating
that the NO production is related to the presence of the
organisms. Previous reports indicated that higher levels of
NO are associated with severe disease [29]. CSF pleocyto-
sis, protein concentration, granulocyte percentage, high
tumor necrosis factor-alpha (TNF-α), low glucose and L-
arginine during the initial stage of meningitis[22,23]. It
has been suggested that beside the bacteria itself, neu-
trophil accumulation in the subarachnoid space is a hall-
mark of the acute inflammatory response in bacterial
meningitis[30]. Activated neutrophils can secrete large
amounts of ROS and a wide variety of potential triggers as
cytokines, complement factors and platelet-activating fac-
tor in the CSF of patients with meningitis [31,32]. Other
possible cell types involved in ROS generation comprise
microglia macrophages, cerebral endothelial cells, astro-
cytes, and neuronal cells[33].
In this study, serum LPO levels were elevated in patients
with meningitis which points to the presence of a general
status of oxidative stress affecting cellular membranes[5-
7,9,26].
In this study, the high levels of NO, regardless of its
source, have been associated with membrane lipid perox-
idation. There is a substantial body of work implicating
ROS, inflammation and oxidative stress in the develop-
ment of cerebral edema, vascular damage, CSF pleocytosis
and intracranial complications in bacterial meningitis and
meningoencepahlitis[5,7]. It is known that the brain is a
target for free radical damage because of its large lipid con-
tent, high quantities of polyunsaturated fatty acids, high
rate of metabolism with high consumption of oxygen,
and low antioxidant capacity[34]. In the present study,
enhancement of antioxidant scavengers' activities were
identified as indicated by elevated levels of total thiol and
SOD. Serum SOD was higher in patients with neurologi-
cal complications than those without. In patients with
positive bacterial culture, the levels of CSF-total thiol and
its index were higher than those with negative cul-
ture[5,6,11]. Some studies reported elevation of CSF lev-
els of antioxidant enzymes and malondialdehyde
(markers of lipid peroxidation) in children with meningi-
tis[35,36]. In contrast, Aycicek et al[7]. found that serum
total oxidant status and lipid hydroperoxide were higher,
but CSF total oxidant status and lipid hydroperoxide were
lower while CSF total antioxidant status was higher in
children with acute bacterial meningitis. Superoxide dis-
mutases (SODs) are metalloenzymes that exists in the
form of three isozymes, namely copper-zinc SOD (Cu/Zn
SOD), manganese SOD (Mn-SOD) and extracellular
SOD, that are widely distributed in human tissues, includ-
ing those of the nervous system[37]. The medical litera-
ture has described SOD as the most important enzyme
involved in the removal of superoxide anions. Hirose et
al[38]. reported that CSF levels of Mn-SOD were elevated
in almost all patients with bacterial meningitis and the
mean level of Mn-SOD was higher than those in patients
with aseptic meningitis and encephalitis, suggesting that
marked elevation of Mn-SOD in the CSF in bacterial men-
ingitis is a phenomenon related to bacterial infection.
In the present study, S-100B concentrations were
increased. The results of S-100B CSF/serum ratio suggest
increased intrathecal synthesis. Its levels were higher in
patients with positive than with negative cultures and in
presence of neurological complication than in their
absence. A positive correlation was identified between
CSF-S-100B and CSF-LPO and between S-100B ratio and
the severity of meningitis as indicated by PGCS. The posi-
tive correlation was found between serum-S-100B with
serum-total thiol lead to the suggestion that the damaged
astrocytes may increase the formation of S-100B accord-
ing to severity of oxidative stress.
S-100B is a low molecular weight mainly brain-derived
protein (intrathecal fraction = ~99%; CSF/serum ratio:
18:1). In healthy subjects, natural autoantibodies of IgG
class to S-100B are present in serum. However, the exact
source of S-100B in the blood is unknown. At normal con-BMC Neurology 2009, 9:51 http://www.biomedcentral.com/1471-2377/9/51
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centrations, it is able to protect hippocampal neurons
against glutamate toxicity[12]. It was already demon-
strated that S-100B suppresses oxidative stress induced by
cupper[39]. While at higher levels (micromolar), it causes
exacerbation of neuroinflammation, oxidative stress and
neuronal apoptosis[40]. Increase in S-100B may reflect
the extent of glial damage or astrocytic reactions to neural
injury (reactive astrogliosis). Gazzolo et al[41]. reported
that S-100B was higher in patients with bacterial meningi-
tis without encephalitis and the presence of a correlation
between S-100B and CSF pleocytosis could offer addi-
tional support to the higher risk of neurological sequelae.
The exact mechanisms that regulate the increased intrath-
ecal levels of S-100B protein in bacterial meningitis are
unknown. Inflammation [42]., glutamate [43]. and oxida-
tive stress [44]. are considered as important stimulants for
S-100B production.
To summarize, the present investigation provides a new
perspective for the clinical study of S-100B, with special
reference to neurologic sequelae after bacterial infections.
We believe that this study has potential clinical impor-
tance in the field of pediatrics and biological processes
although the results of this work in some of its parts are
confirmatory to the previously established data and our
suggestions of their role in the pathogenesis of bacterial
meningitis are speculative in nature. This is the main lim-
itation of this study. Further experimental studies are
needed to confirm the direct or indirect causal relation-
ship between bacteria, inflammation, oxidative stress and
S-100B, markers in the pathogenesis of bacterial meningi-
tis. Although CSF remains the biological fluid of choice,
further investigations are needed in other biological flu-
ids.
Conclusion
The results of this study may have clinical and research
implications. It may contribute to further understanding
of factors involved in the pathogenesis of brain compro-
mise in bacterial meningitis. It seems to be multifactorial
and not due to direct infection of CSF or to the presence
of toxins. It involves disruption of the blood-CSF barriers
caused by inflammatory process, oxidative stress and
impaired astrocyte function. If the results of this study are
supported by further research, this may lead to the use of
distinct profiles of mediators as possible biomarkers for
the prediction of prognosis, monitoring response to treat-
ment and improvement of management strategies of
patients with bacterial meningitis.
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